7 research outputs found
CARDIOVASCULAR SYSTEM INJURIES IN PATIENTS WITH COVID-19. Review
Relevance. The outbreak of new coronavirus disease (COVID-19) caused by SARS-CoV-2 is the biggest medical problem of the 21st century.
Every year, humanity is faced with new diseases of viral etiology, the unpredictable occurrence and severe manifestations of which often lead to the stupor of scientists and physicians around the world. Although the virus primarily affects the lungs, and the clinical manifestations of the disease are dominated by respiratory symptoms, but it significantly affects the risk of development and clinical course of cardiovascular disease. It should be noted that heart disease with COVID-19 can be observed in patients with chronic diseases of the cardiovascular system, as well as in patients who had no signs of heart disease before this infection.
Objective: to consider current data on cardiovascular disease in patients with COVID-19.
Methods. Analysis of latest data presented in PubMed by keywords "COVID-19", "SARS-CoV-2", "pandemic", "cardiovascular disease", "myocardial infarction". Search depth β 2 years (2020-2022), with retrospective deepening of some positions until 2003.
Results. Coronavirus interacts with the cardiovascular system on many levels, increasing the incidence of patients with concomitant cardiovascular disease and provoking myocardial damage and dysfunction. In addition, cardiovascular disease in patients with coronavirus disease may pose an increased risk of mortality. Therefore, an understanding of the damage to SARS-CoV-2 to the cardiovascular system and its underlying mechanisms is of the utmost importance to ensure that the treatment of these patients is timely and effective and that mortality is reduced.
Conclusions. COVID-19, caused by SARS-CoV-2, is a global pandemic that is evolving in real time. Concomitant cardiovascular disease is common in patients on COVID-19, and these patients have a higher risk of morbidity and mortality. Therefore, in addition to routine examinations for coronavirus disease, patients with cardiovascular disease should receive ancillary studies of the heart and blood vessels, such as cardiac biomarkers, cardiac imaging, electrocardiography, echocardiography and angiography
Medico-statistical analysis of the incidence of pneumonia, including those caused by COVID-19 in the Chernivtsi region during 2018-2021
ΠΠ΄Π½ΡΡΡ Π· Π½Π°ΠΉΠ±ΡΠ»ΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΈΡ
ΠΏΡΠΎΠ±Π»Π΅ΠΌ ΡΡΡΠ°ΡΠ½ΠΎΡ ΠΎΡ
ΠΎΡΠΎΠ½ΠΈ Π·Π΄ΠΎΡΠΎΠ²βΡ Π½Π°ΡΠ°Π·Ρ Ρ Π²ΡΡΡΡΠ½Π° ΡΠ½ΡΠ΅ΠΊΡΡΡ, Π²ΠΈΠΊΠ»ΠΈΠΊΠ°Π½Π° SARS-CoV-2, ΡΠΎ Π½Π°Π±ΡΠ»Π° ΡΠΊ Π²Π°Π³ΠΎΠΌΠΎΠ³ΠΎ ΠΌΠ΅Π΄ΠΈΡΠ½ΠΎΠ³ΠΎ, ΡΠ°ΠΊ Ρ ΡΡΡΠΏΡΠ»ΡΠ½ΠΎΠ³ΠΎ Π·Π½Π°ΡΠ΅Π½Π½Ρ. ΠΡΠ΅ΡΠ²ΡΡΠ½Ρ ΠΎΡΠ³Π°Π½ΡΠ·Π°ΡΡΡ ΠΎΡ
ΠΎΡΠΎΠ½ΠΈ Π·Π΄ΠΎΡΠΎΠ²βΡ 11 Π±Π΅ΡΠ΅Π·Π½Ρ 2020 Ρ. ΠΎΠ³ΠΎΠ»ΠΎΡΠΈΠ»Π° ΠΏΠ°Π½Π΄Π΅ΠΌΡΡ COVID-19. ΠΠ°Ρ
Π²ΠΎΡΡΠ²Π°Π½Π½Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΡΡΡ ΠΏΠΎΠ»ΡΠΌΠΎΡΡΡΠ·ΠΌΠΎΠΌ ΠΊΠ»ΡΠ½ΡΡΠ½ΠΎΡ ΠΊΠ°ΡΡΠΈΠ½ΠΈ, Π²ΡΠ΄ ΡΡΠ°ΠΆΠ΅Π½Π½Ρ Π΄ΠΈΡ
Π°Π»ΡΠ½ΠΈΡ
ΡΠ»ΡΡ
ΡΠ² Π΄ΠΎ Π²ΠΈΡΠ°ΠΆΠ΅Π½ΠΈΡ
ΠΊΠΈΡΠΊΠΎΠ²ΠΈΡ
ΠΏΡΠΎΡΠ²ΡΠ², ΠΎΠ΄Π½Π°ΠΊ Π½Π°ΠΉΠ±ΡΠ»ΡΡ ΡΡΠΆΠΊΠΎΡ ΡΠΎΡΠΌΠΎΡ Π·Π°Π»ΠΈΡΠ°ΡΡΡΡΡ Π²ΡΡΡΡΠ½Ρ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΡΡ, ΡΠΏΡΠΈΡΠΈΠ½Π΅Π½Ρ COVID-19.
One of the most urgent problems of modern health care is currently a viral infection caused by SARS-CoV-2, which has acquired both significant medical and social significance. The World Health Organization declared the COVID-19 pandemic on March 11, 2020. The disease is characterized by a polymorphism of the clinical picture from damage to the respiratory tract to pronounced intestinal manifestations, nevertheless, the most severe form remains viral pneumonia caused by COVID-19
Epidemiological characteristics SAR-CoV-2 Omicron
Π Π΅Π·ΡΠΌΠ΅. Π¨ΡΠ°ΠΌ ΠΠΌΡΠΊΡΠΎΠ½ Π²ΠΏΠ΅ΡΡΠ΅ Π·Π°ΡΠ΅ΡΡΡΡΠΎΠ²Π°Π½ΠΎ ΠΠΠΠ Ρ ΠΡΠ²Π΄Π΅Π½Π½ΡΠΉ ΠΡΡΠΈΡΡ 24 Π»ΠΈΡΡΠΎΠΏΠ°Π΄Π° 2021 Ρ. Π‘ΡΠ°Π½ΠΎΠΌ Π½Π° ΠΏΠΎΡΠ°ΡΠΎΠΊ 2022 Ρ. Π²ΠΈΠΏΠ°Π΄ΠΊΠΈ Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Π½Ρ Π½Π° ΠΠΌΡΠΊΡΠΎΠ½ Π·Π°ΡΠ΅ΡΡΡΡΠΎΠ²Π°Π½ΠΎ Ρ ΠΏΠΎΠ½Π°Π΄ 60 ΠΊΡΠ°ΡΠ½Π°Ρ
ΡΠ° ΡΠ΅Π³ΡΠΎΠ½Π°Ρ
ΡΠ²ΡΡΡ. ΠΠ°ΡΠ°Π·Ρ ΠΠΌΡΠΊΡΠΎΠ½ Ρ Π΄ΠΎΠΌΡΠ½ΡΡΡΠΈΠΌ Ρ ΡΠ²ΡΡΡ ΡΡΠ°ΠΌΠΎΠΌ SAR-CoV-2 Π·Ρ ΡΡ
ΠΈΠ»ΡΠ½ΡΡΡΡ Π΄ΠΎ ΡΠ²ΠΈΠ΄ΠΊΠΎΠ³ΠΎ ΡΠΎΠ·ΠΏΠΎΠ²ΡΡΠ΄ΠΆΠ΅Π½Π½Ρ. Π₯ΠΎΡΠ° Ρ
Π²ΠΎΡΠΎΠ±Π°, Π²ΠΈΠΊΠ»ΠΈΠΊΠ°Π½Π° ΠΠΌΡΠΊΡΠΎΠ½ΠΎΠΌ, ΠΌΠ°Ρ ΠΏΠ΅ΡΠ΅Π²Π°ΠΆΠ½ΠΎ Π±Π΅Π·ΡΠΈΠΌΠΏΡΠΎΠΌΠ½ΠΈΠΉ ΡΠΈ Π»Π΅Π³ΠΊΠΈΠΉ ΠΏΠ΅ΡΠ΅Π±ΡΠ³, ΡΡΡΡΠΌΠΊΠ΅ Π·ΡΠΎΡΡΠ°Π½Π½Ρ ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΠ° Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½ΠΎΡΡΡ ΠΌΠΎΠΆΠ΅ Π²ΠΈΠΊΠ»ΠΈΠΊΠ°ΡΠΈ ΡΠ΅ΡΠΉΠΎΠ·Π½Π΅ Π½Π°Π²Π°Π½ΡΠ°ΠΆΠ΅Π½Π½Ρ Π½Π° Π³Π»ΠΎΠ±Π°Π»ΡΠ½Ρ ΡΠΈΡΡΠ΅ΠΌΡ ΠΎΡ
ΠΎΡΠΎΠ½ΠΈ Π·Π΄ΠΎΡΠΎΠ²'Ρ. ΠΠΊΡΡΠΌ Π²ΠΈΡΠ΅Π·Π°Π·Π½Π°ΡΠ΅Π½ΠΎΠ³ΠΎ, Π΄ΠΆΠ΅ΡΠ΅Π»Π° ΠΌΡΡΠ°ΡΡΠΉ, Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΡ Π·Π±ΡΠ΄Π½ΠΈΠΊΠ°, ΠΉΠΎΠ³ΠΎ ΡΡΡΠΉΠΊΡΡΡΡ Π΄ΠΎ Π²Π°ΠΊΡΠΈΠ½ Ρ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠ½ΡΠΎ Π²ΠΈΠ²ΡΠ΅Π½ΠΈΠΌΠΈ, ΡΠΈΠΌ Π·ΡΠΌΠΎΠ²Π»Π΅Π½Π° ΠΏΠ΅ΡΠ΅ΠΏΠΎΠ½Π° Ρ Π±ΠΎΡΠΎΡΡΠ±Ρ Π·Ρ Π·Π±ΡΠ΄Π½ΠΈΠΊΠΎΠΌ Ρ ΡΡΠ·Π½ΠΈΡ
ΡΠ΅Π³ΡΠΎΠ½Π°Ρ
ΡΠ²ΡΡΡ. Π£ Π΄Π°Π½ΡΠΉ ΡΡΠ°ΡΡΡ ΠΏΡΠΎΠ°Π½Π°Π»ΡΠ·ΠΎΠ²Π°Π½ΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΈ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Ρ ΡΠΎΠ΄ΠΎ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ Π·Π±ΡΠ΄Π½ΠΈΠΊΠ°, ΠΉΠΎΠ³ΠΎ ΠΌΡΠ½Π»ΠΈΠ²ΠΎΡΡΡ, ΠΎΡΠΎΠ±Π»ΠΈΠ²ΠΎΡΡΠ΅ΠΉ ΠΏΠ΅ΡΠ΅Π΄Π°ΡΡ ΡΠ° ΠΌΠΎΠΆΠ»ΠΈΠ²ΠΈΡ
ΠΌΠ΅Ρ
Π°Π½ΡΠ·ΠΌΡΠ² ΡΡ ΡΠ΅Π°Π»ΡΠ·Π°ΡΡΡ, Π΅ΠΏΡΠ΄Π΅ΠΌΡΡΠ½ΠΎΠ³ΠΎ ΡΡΠ°ΡΡΡΡ, ΠΌΠΎΠΆΠ»ΠΈΠ²ΠΎΡΡΠ΅ΠΉ ΠΏΡΠΎΡΡΠ»Π°ΠΊΡΠΈΠΊΠΈ ΡΠ° ΡΠ½ΡΠΈΡ
ΠΏΡΠΎΡΠΈΠ΅ΠΏΡΠ΄Π΅ΠΌΡΡΠ½ΠΈΡ
Π·Π°Ρ
ΠΎΠ΄ΡΠ², Π· ΠΌΠ΅ΡΠΎΡ ΡΠΎΠ·ΡΠΎΠ±ΠΊΠΈ Π·Π°Ρ
ΠΎΠ΄ΡΠ² ΡΠΎΠ΄ΠΎ Π±ΠΎΡΠΎΡΡΠ±ΠΈ Π· ΡΠΈΠΌ ΡΡΠ°ΠΌΠΎΠΌ SAR-CoV-2.
Resume. The Omicron strain was first registered by WHO in South Africa on November 24, 2021. As of early 2022, cases of Omicron had been registered in more than 60 countries and regions. The Omicron is currently the world's dominant strain of SAR-CoV-2 with a propensity to spread rapidly. Although diseases caused by Omicron are predominantly asymptomatic and mild, rapid growth or morbidity may seriously overwhelm the global health system. In addition to the above, its sources of mutations, the nature of infection transmission and its resistance to vaccines have not been fully studied yet. This insufficient knowledge leads to obstacles in the fight against a pathogen in different regions of the world. This article analyzes the results of the research on the characteristics of the pathogen, its variability, transmission characteristics and possible implementation mechanisms, epidemic status, prevention and other anti-epidemic measures to develop against the strain of SAR-CoV-2